| http://www.w3.org/ns/prov#value | - Although Novartis???s repeated legal attacks on 3(d) were aiming to ensure even more patents were granted in India including on existing medicines, the company has raised concerns about the implications of the decision on the larger question of financing of medical innovation.
|
